In Boston they ask, how much does he know? In New York, how much is he worth? In Philadelphia, who were his parents?

Tomorrow night I appear for the first time before a Boston audience 4000 critics.

I don't see material upside or downside (for Boston Scientific shares) for the next 12 months.

If the deals went to shareholders today, we believe Boston Scientific would prevail.

It's great to be back here in Boston,

From a competitive standpoint, probably the most sensitive issues are in the Boston and Massachusetts areas. There's going to be some risk to Fleet's dominance there, but I'm not really concerned.